𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

Book ID
117283967
Publisher
The Lancet
Year
2003
Tongue
English
Weight
131 KB
Volume
361
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Topotecan versus treosulfan, an alkylati
Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)
✍ Werner Meier; Andreas du Bois; Alexander Reuss; Walther Kuhn; Sigrid Olbricht; M πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 545 KB
Randomised controlled trial comparing si
Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the β€˜Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group
✍ Buda, A; Floriani, I; Rossi, R; Colombo, N; Torri, V; Conte, P F; Fossati, R; Ra πŸ“‚ Article πŸ“… 2004 πŸ› Nature Publishing Group 🌐 English βš– 116 KB